title: Early healing pattern of statin-induced osteogenesis.
abstract: We examined the early histological expressions of vascular endothelial growth factor (VEGF), bone morphogenetic protein (BMP)-2 and core binding factor (Cbfa1) in healing bones with and without a statin (simvastatin). Thirty bone defects were created in the parietal bones of 15 New Zealand white rabbits. In the statin group (n=9), the defects were grafted with carriers of collagen matrix mixed with simvastatin solution, and the animals were killed on days 1 (n=1), 2 (n=1), 3 (n=2), 4 (n=2), 5 (n=2) and 6 (n=1) after operation. In the collagen matrix group, the defects were grafted with carriers of collagen matrix mixed with water for injection, and killed on days 1-6 postoperatively. Immunolocalisation studies of the defects grafted with statin showed that VEGF was expressed on day 3 postoperatively, BMP-2 on day 4, Cbfa1 on day 5 and that new bone was formed by day 5. These events occurred one day earlier than in the group grafted with the carrier alone. The statin induced and accelerated formation of bone locally, and triggered the early expression of growth factors that regulate angiogenesis, differentiation of bone cells, and osteogenesis.
authors.affiliation: University of Hong Kong, Government of Hong Kong, SAR, Hong Kong. fyoung@pacific.net.hk
authors.forename: Ricky W K
authors.initials: RW
authors.lastname: Wong
authors.forename: A Bakr M
authors.initials: AB
authors.lastname: Rabie
mesh_terms: D000818:Animals; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000096:biosynthesis; D001842:Bone and Bones / Q000378:metabolism*; D003094:Collagen; D050657:Core Binding Factor alpha Subunits; D004268:DNA-Binding Proteins / Q000096:biosynthesis; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D007150:Immunohistochemistry; D010012:Osteogenesis / Q000187:drug effects*; D014677:Pharmaceutical Vehicles; D011817:Rabbits; D019821:Simvastatin / Q000494:pharmacology*; D012886:Skull / Q000601:surgery; D014157:Transcription Factors / Q000096:biosynthesis; D016212:Transforming Growth Factor beta / Q000096:biosynthesis; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D050657:Core Binding Factor alpha Subunits; D004268:DNA-Binding Proteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D014677:Pharmaceutical Vehicles; D014157:Transcription Factors; D016212:Transforming Growth Factor beta; D042461:Vascular Endothelial Growth Factor A; C406688:core binding factor alpha; D003094:Collagen; D019821:Simvastatin